ArticleStroke research and treatment2026
Monocyte-to-Albumin Ratio (MAR) Is Associated With All-Cause Mortality in Adult Stroke Patients: Evidence From NHANES (1999-2018).
Article in Stroke research and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Monocyte-to-Albumin Ratio (MAR) Is Associated With All-Cause Mortality in Adult Stroke Patients: Evidence From NHANES (1999-2018).Stroke research and treatment · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the association between the monocyte-to-albumin ratio (MAR) and all-cause mortality risk in stroke patients. Methods: We analyzed data from 2022 stroke participants (aged ≥ 20 years) in the National Health and Nutrition Examination Survey (NHANES) 1999-2018. MAR was calculated as the monocyte count (×10 Results: A total of 2022 participants were included, of whom 1016 (50.2%) were male and 1506 (74.5%) were aged ≥ 60 years. In multivariable Cox regression adjusting for demographic, lifestyle, and clinical covariates, elevated MAR was independently associated with all-cause mortality (per 1-unit increase: HR = 1.35, 95% CI: 1.21-1.50; T3 vs. T1: HR = 1.32, 95% CI: 1.12-1.55; both Conclusion: Elevated MAR is independently associated with long-term mortality in stroke survivors, reflecting underlying inflammation and nutritional insufficiency. These findings support MAR's potential utility as a research tool in prospective cohort studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.